A carregar...

Commercial Opportunities and Ethical Pitfalls in Personalized Medicine: A Myriad of Reasons to Revisit the Myriad Genetics Saga

In 1996, the US-based biotechnology company Myriad Genetics began offering genetic diagnostic tests for mutations in the genes BRCA1 and BRCA2, which are linked to hereditary breast and ovarian cancer. Since that time, Myriad has been a forerunner in the field of personalized medicine through the us...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: So, Derek, Joly, Yann
Formato: Artigo
Idioma:Inglês
Publicado em: Bentham Science Publishers 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3715893/
https://ncbi.nlm.nih.gov/pubmed/23885284
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1875692111311020003
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!